APOC3 and fatty liver disease: Similarly, when comparing patients with CC versus CT/TT genotypes of ApoC-III rs2854117/MspI, no significant differences (p > 0.05) were found in the presence of hepatic steatosis, liver cirrhosis, dyslipidemia, hypertriglyceridemia, hypercholesterolemia, diabetes status, complications, or cardiovascular disease (Table 5 and Table 6).